Capability of Utilizing CYP3A5 Polymorphisms to Predict Therapeutic Dosage of Tacrolimus at Early Stage Post-Renal Transplantation

While CYP3A5 polymorphisms are used to predict the initial dosage of tacrolimus therapy, the predictive capability of genetic information for dosing at early stage post-renal transplantation is unknown. We investigated the influence of polymorphisms over time. An initial oral dose of modified-releas...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Main Authors: Niioka, Takenori, Kagaya, Hideaki, Saito, Mitsuru, Inoue, Takamitsu, Numakura, Kazuyuki, Habuchi, Tomonori, Satoh, Shigeru, Miura, Masatomo
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307337/
https://ncbi.nlm.nih.gov/pubmed/25594874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms16011840
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares